These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34567823)

  • 1. Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: Potential role in prevention and management of COVID-19.
    Manjunath SH; Thimmulappa RK
    J Pharm Anal; 2022 Feb; 12(1):29-34. PubMed ID: 34567823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Malekmohammad K; Rafieian-Kopaei M
    Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19.
    Thimmulappa RK; Mudnakudu-Nagaraju KK; Shivamallu C; Subramaniam KJT; Radhakrishnan A; Bhojraj S; Kuppusamy G
    Heliyon; 2021 Feb; 7(2):e06350. PubMed ID: 33655086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic implications of quercetin and its derived-products in COVID-19 protection and prophylactic.
    Ho WY; Shen ZH; Chen Y; Chen TH; Lu X; Fu YS
    Heliyon; 2024 May; 10(9):e30080. PubMed ID: 38765079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect and mechanism of quercetin or quercetin-containing formulas against COVID-19: From bench to bedside.
    Chen JY; Huang TR; Hsu SY; Huang CC; Wang HS; Chang JS
    Phytother Res; 2024 Jun; 38(6):2597-2618. PubMed ID: 38479376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Immunomodulatory Properties of Biologically Active Components of Spices Against SARS-CoV-2 and Pan β-Coronaviruses.
    Sengupta S; Bhattacharyya D; Kasle G; Karmakar S; Sahu O; Ganguly A; Addya S; Das Sarma J
    Front Cell Infect Microbiol; 2021; 11():729622. PubMed ID: 34513735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of BEN815 as an anti-inflammatory, antiviral and antioxidant agent for the treatment of COVID-19.
    Shin JA; Oh S; Jeong JM
    Phytomed Plus; 2021 Nov; 1(4):100058. PubMed ID: 35403084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory potential of Quercetin in COVID-19 treatment.
    Saeedi-Boroujeni A; Mahmoudian-Sani MR
    J Inflamm (Lond); 2021 Jan; 18(1):3. PubMed ID: 33509217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on plant flavonoid quercetin-based drugs for novel SARS-CoV-2.
    Saakre M; Mathew D; Ravisankar V
    Beni Suef Univ J Basic Appl Sci; 2021; 10(1):21. PubMed ID: 33782651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications.
    Fratta Pasini AM; Stranieri C; Cominacini L; Mozzini C
    Antioxidants (Basel); 2021 Feb; 10(2):. PubMed ID: 33578849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses.
    Fung SY; Yuen KS; Ye ZW; Chan CP; Jin DY
    Emerg Microbes Infect; 2020; 9(1):558-570. PubMed ID: 32172672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyanobacteria and Algae-Derived Bioactive Metabolites as Antiviral Agents: Evidence, Mode of Action, and Scope for Further Expansion; A Comprehensive Review in Light of the SARS-CoV-2 Outbreak.
    Pradhan B; Nayak R; Patra S; Bhuyan PP; Dash SR; Ki JS; Adhikary SP; Ragusa A; Jena M
    Antioxidants (Basel); 2022 Feb; 11(2):. PubMed ID: 35204236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
    Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
    J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical evaluation of risk to reward ratio of quercetin supplementation for COVID-19 and associated comorbid conditions.
    Pawar A; Russo M; Rani I; Goswami K; Russo GL; Pal A
    Phytother Res; 2022 Jun; 36(6):2394-2415. PubMed ID: 35393674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colchicine in the management of Covid-19: With or lieu of evidence.
    Al-Kuraishy HM; Hussien NR; Al-Niemi MS; Al-Gareeb AI
    J Pak Med Assoc; 2021 Dec; 71(Suppl 8)(12):S127-S132. PubMed ID: 35130235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoquercetin as an Anti-Covid-19 Medication: A Potential to Realize.
    Mbikay M; Chrétien M
    Front Pharmacol; 2022; 13():830205. PubMed ID: 35308240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.